Excessive refilling is common practice at U.S. mail-order pharmacies, a Journal analysis of Medicare prescription data found, flooding the homes of seniors with extra drugs. Too-frequent refills by all U.S. pharmacies cost Medicare and patients $3 billion between 2021 and 2023, the analysis found.

Congress is debating health insurance this week. A bipartisan deal is unlikely. It’s achievable, though. I know that because last week I introduced bipartisan drug-pricing legislation.

Excessive refilling is common practice at U.S. mail-order pharmacies, a Journal analysis of Medicare prescription data found, flooding the homes of seniors with extra drugs. Too-frequent refills by all U.S. pharmacies cost Medicare and patients $3 billion between 2021 and 2023, the analysis found.

Companies like CVS, Express Scripts, and Optum RX sued the state claiming the law harms interstate commerce and puts them at a competitive disadvantage. Under the act, PBM's would either have to cease operations in Arkansas or close pharmacies that they operate.

In other words: "PBMs pay libertarian lobby firm to write a hit piece about new West Virginia law"

The first of its kind in the country, this advisory from the Louisiana Department of Insurance directs PBMs on adopting a “cost plus” methodology (considered the gold standard for reimbursement reform) after the passing of state legislation establishing new reimbursement requirements.

Members of MNIndys leadership—Vice President John Hoeschen, RPh and Secretary & Treasurer Andrew Russell, RPh—were both in attendance at the press conference on the Hill as their fellow independent pharmacy owners shared their stories and pleaded for action.

“We really put as much effort as we possibly could have into making sure this place was successful. Unfortunately the harsh reality of business ownership is you’re met with your expectations versus reality,” [Austin] Bailey said.

Longtime Winsted pharmacist and Keaveny Drug owner Deb Keaveny has been selected as the grand marshal for this year’s Winsted Winter Festival, a recognition that highlights her two decades of business success and community service.

The settlement resolves charges that CVS violated the federal False Claims Act between January 1, 2010 and December 31, 2020 by dispensing more insulin pens than doctors prescribed, obtaining reimbursements for premature refills, and underreporting how much insulin its pharmacies dispensed.